Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use
Introduction Gastroenterocolitis is one of the adverse events related to immune checkpoint inhibitors. However, inflammation of the intestinal lesion used for urinary diversion is not well known as an adverse event related to their use. Case presentation A patient with metastatic bladder cancer was...
Saved in:
| Main Authors: | Ko Kobayashi, Kohei Hashimoto, Toshiaki Tanaka, Naoya Masumori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | IJU Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iju5.12797 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of vitiligo with immune-checkpoint inhibitor therapy: A systematic review
by: Lauren Fleshner, MSc, et al.
Published: (2025-02-01) -
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer
by: Renate Pichler, et al.
Published: (2024-12-01) -
A rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy
by: Koichiro Uehara, et al.
Published: (2025-01-01) -
Immune-Related Adverse Events in a Patient Treated with Pembrolizumab: A Case Report from the Point of View of a Geriatrician
by: Philipp Oft, et al.
Published: (2024-12-01) -
Unusual gingival presentation following treatment with pembrolizumab
by: Annu Singh, et al.
Published: (2024-03-01)